Sexually Transmitted Infections Clinical Trials Group

性传播感染临床试验组

• 批准号: 8513195
• 负责人: EDWARD HOOK III
• 金额: $ 148.7万
• 依托单位: UNIVERSITY OF ALABAMA AT BIRMINGHAM
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-09-29 至 2014-01-08
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8513195
• 关键词: Adolescent; Area; Bacterial Vaginosis; Biological; Clinical Research; Clinical Trials; Clinical Trials Cooperative Group; Contractor; Contracts; Developing Countries; High Prevalence; Incidence; Laboratory Personnel; Leadership; Phase III Clinical Trials; Population; Prevalence; Research Infrastructure; Sexually Transmitted Diseases; Therapeutic; Training; Woman; clinical research site; experience; protocol development; sample collection

The Sexually Transmitted Infections Clinical Trials Group provides infrastructure to conduct sexually transmitted infections (STIs) related clinical research, including providing clinical sites, trained and experienced personnel, laboratories, protocol development, clinical trial coordination, biological sample collection, storage, scientific leadership, and other aspects related to the conduct of clinical studies. The contractor must have access to populations with documented incidence and prevalence of STIs. This may include populations that consist of women, adolescents, and those in areas where there is a very high prevalence of STIs, such as developing countries.

性传播感染临床试验组提供了进行性传播感染（ETI）相关的临床研究的基础设施，包括提供临床部位，训练和经验丰富的人员，实验室，方案开发，临床试验协调，生物样品收集，存储，科学领导，科学领导以及与临床研究有关的其他方面。承包商必须可以使用有记录的性传播感染率和患病率的人口。这可能包括包括妇女，青少年以及在发展中国家等较高患病率的地区的人群。